NCT04456218

Brief Summary

A disposable endoscopy system (NCKU-scope-01) was developed for the evaluation of bile duct stone or neoplasm. This system consists of a camera, light sources, a working channel, and a water injection channel. The endoscope could be inserted into the common bile duct via the working channel of a commercial duodenoscope. This study aims to test the feasibility and safety of this system. The efficacy of stone and neoplasm diagnosis will also be analyzed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
14

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jul 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 14, 2020

Completed
17 days until next milestone

Study Start

First participant enrolled

July 1, 2020

Completed
1 day until next milestone

First Posted

Study publicly available on registry

July 2, 2020

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2021

Completed
Last Updated

August 2, 2022

Status Verified

July 1, 2022

Enrollment Period

12 months

First QC Date

June 14, 2020

Last Update Submit

July 29, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • A complete common bile duct accessing rate

    To test the device's feasibility

    1 day

  • Image quality evaluation: the light brightness and the imaging sharpness in Likert scale

    To test the device's feasibility. About Likert scale, it range from 1 to 5 (1 is worse and 5 is better).

    1 day

Secondary Outcomes (3)

  • Number of complications (ablation, bleeding, perforation in percentage) or system malfunction

    1 day

  • In biliary stone arm: The biggest residual stone size (in cm).

    1 day

  • In biliary stricture arm: Number of the lesions with or without presenting of the specific features for DDx of the benign or malignant stricture

    1 day

Study Arms (2)

Biliary stone

EXPERIMENTAL

Participants who meet the criteria of biliary stone enrollment and are willing to join in this study will be applied to the custom-made endoscope system for biliary disease diagnosis.

Device: NCKU-scope-01 (a custom-made biliary endoscope system)

Biliary stricture

EXPERIMENTAL

Participants who meet the criteria of biliary neoplasm enrollment and are willing to join in this study will be applied to the custom-made endoscope system for biliary disease diagnosis.

Device: NCKU-scope-01 (a custom-made biliary endoscope system)

Interventions

The NCKU-scope-01 is a custom-made endoscope system for this study and it will be applied to help biliary disorders diagnosis

Biliary stoneBiliary stricture

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with complicated bile duct stone (stone size \> 1.5 cm or number of stone \> 3 )
  • Patients with indeterminate biliary stricture or obstruction

You may not qualify if:

  • Pregnant woman;
  • Patients who are not suitable for ERCP (e.g. behavior disorder, major cognitive-perceptual deficit, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Cheng Kung University Hospital

Tainan, 704, Taiwan

Location

MeSH Terms

Conditions

NeoplasmsCholecystolithiasis

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesGallbladder Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

June 14, 2020

First Posted

July 2, 2020

Study Start

July 1, 2020

Primary Completion

June 30, 2021

Study Completion

December 31, 2021

Last Updated

August 2, 2022

Record last verified: 2022-07

Locations